Accès ouvert
2026
article
OpenAlex
Aparna Hari, Neeraj Sidharthan, Manoj Unni, Hisham Ahamed
Cardiac involvement determines prognosis in systemic AL amyloidosis, and functional cardiac recovery typically lags hematologic response by months to years.
in
(code pays fourni par la source)
2026
article
OpenAlex
Hridhya K. Sidharthan, Mansi Goel, Manoj Unni, Neeraj Sidharthan et autres
in
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Neeraj Sidharthan, Vivek Ananda Chood O M, Anandakrishnan Nandakumar, Georg Gutjahr et autres
Abstract Background: Systemic light chain (AL) Amyloidosis is a rare plasma cell dyscrasia with an estimated global incidence of 10–15 cases per million annually. The true burden is likely underrecognized in low- and middle-income countries (LMICs), where diagnostic delays are common due …
in
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Gopal Nandkishor Sinhal, Monisha Harimadhavan, Gayathri Sajeevan, Anandakrishnan Nandakumar et autres
Abstract Background: CD19-directed CAR-T cell therapies have significantly improved outcomes in relapsed/refractory (R/R) B-cell malignancies, including acute lymphoblastic leukemia (B-ALL) and non-Hodgkin lymphoma (B-NHL). Despite their efficacy, these therapies are associated with serious early toxicities, particularly cytokine release syndrome (CRS) and immune …
in
(code pays fourni par la source)
2025
article
OpenAlex
G S Reshmy, Sajitha Krishnan, Manoj Unni, Georg Gutjahr et autres
in
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Suchitra Sivadas, Vivek Kumar Ambastha, U. Gopikrishnan, Manoj Unni et autres
in
(code pays fourni par la source)
2024
conference-abstract
OpenAlex
Gohul Gopi Jalajakumari, Manoj Unni, Vidya Jha, Bindhu Paul‐Prasanth et autres
Introduction Paroxysmal Nocturnal Hemoglobinuria (PNH) is a chronic acquired disorder that can cause hemolysis, thrombosis and aplastic marrow , with an incidence of 1-10 cases per million people. Studies focusing on PNH in the Indian population are relatively sparse. Although C5 inhibitors …
in
(code pays fourni par la source)
2024
conference-abstract
OpenAlex
Shreya Gopal Agrawal, Gopal Nandkishor Sinhal, Manoj Unni, Monisha Harimadhavan et autres
Background: CAR-T cell therapy, while revolutionary for treating relapsed or refractory hematologic malignancies, faces economic and logistical hurdles in low and middle-income countries (LMIC) such as India (per-capita income of $2,100 compared to US $81,000). With treatment costs ranging from $300,000 to …
in
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Jeny Jimmy, Vidya Jha, GA Ajeesh, B Aryalakshmi et autres
We convey our sincere thanks to Jain et al.[1] for providing insightful commentary on our study “Clinical utility of 7-probe FISH panel in multiple myeloma in a resource-constrained setting: A retrospective and prospective observational study.”[2] (i) The authors have noted that there …
in
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Jeny Jimmy, Vidya Jha, GA Ajeesh, B Aryalakshmi et autres
ABSTRACT Background: A 7-probe fluorescence in situ hybridization (FISH) panel identifying abnormalities such as immunoglobulin heavy chain (IGH) rearrangement, deletion 17p (TP53 – tumor protein 53), hyperdiploidy, and amplification of 1q, t(11;14), t(14;16), and t(4;14) aids in diagnosis and treatment planning for …
in
(code pays fourni par la source)
2023
conference-abstract
OpenAlex
Chitresh Yadav, Manoj Unni, Monisha Harimadhavan, Rema Ganapathy et autres
Introduction: Acute Myeloid Leukemia (AML) is a highly aggressive and genetically heterogeneous hematologic malignancy with a potentially fatal outcome if left untreated. The standard treatment, the 7+3 regimen, involving intensive chemotherapy, has been the cornerstone of therapy for decades. However, this approach …
in
(code pays fourni par la source)
Accès ouvert
2023
conference-abstract
OpenAlex
Monisha Harimadhavan, Manoj Unni, Rema Ganapathy, Suchitra Sivadas et autres
Introduction: Antiphospholipid syndrome (APS) is known for its association with unexplained vascular thrombosis and pregnancy-related complications. However, APS can also present with various hematological abnormalities, including thrombocytopenia, autoimmune hemolytic anemia, Evan's syndrome, and thrombotic microangiopathy. While APS is often considered in patients …
in
(code pays fourni par la source)